$1.33
0.010.76%
At Close: -
$1.38
0.053.77%
After Hours: 7:46 PM EDT
15 minutes delayed
Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics | -$0.42 | -$0.20 | — | — | $1.87M | $1.82M | — | — | 08/05/2024 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.42 | -$0.29 | -$0.24 | 17.24% | $2.53M | $1.37M | $2.40M | 75.04% | 05/07/2024 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.41 | -$0.34 | -$0.30 | 11.76% | $7.75M | $3.36M | $17.57M | 422.92% | 02/27/2024 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.30 | -$0.48 | -$0.41 | 14.58% | $19.02M | $1.57M | $9.28M | 491.21% | 11/06/2023 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.31 | -$0.45 | -$0.42 | 6.67% | $1.53M | $1.90M | $1.87M | -1.63% | 08/07/2023 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.31 | -$0.44 | -$0.42 | 4.55% | $1.45M | $1.75M | $2.53M | 44.46% | 05/08/2023 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.37 | -$0.45 | -$0.41 | 8.89% | $1.50M | $1.99M | $7.75M | 289.60% | 02/23/2023 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.35 | -$0.40 | -$0.30 | 25.00% | $1.66M | $1.60M | $19.02M | 1088.62% | 11/08/2022 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.34 | -$0.36 | -$0.31 | 13.89% | $1.82M | $1.61M | $1.53M | -5.09% | 08/03/2022 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.57 | -$0.40 | -$0.31 | 22.50% | $1.78M | $1.66M | $1.45M | -12.47% | 05/10/2022 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.30 | -$0.36 | -$0.37 | -2.78% | $1.58M | $1.79M | $1.50M | -16.15% | 02/24/2022 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.25 | -$0.28 | -$0.35 | -25.00% | $1.45M | $1.77M | $1.66M | -6.27% | 11/02/2021 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.28 | -$0.29 | -$0.34 | -17.24% | $2.05M | $1.69M | $1.82M | 7.93% | 08/05/2021 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.37 | -$0.29 | -$0.57 | -96.55% | $1.41M | $1.69M | $1.78M | 5.15% | 05/07/2021 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.45 | — | -$0.30 | — | $1.09M | — | $1.58M | — | 02/25/2021 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.56 | — | -$0.25 | — | $983.00K | — | $1.45M | — | 11/04/2020 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.76 | — | -$0.28 | — | $5.87M | — | $2.05M | — | 08/07/2020 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.91 | — | -$0.37 | — | $1.26M | — | $1.41M | — | 05/07/2020 | Get Alert |
ACRS | Aclaris Therapeutics | -$0.99 | -$1.24 | -$0.45 | 63.71% | $3.67M | $3.47M | $1.09M | -68.44% | 02/25/2020 | Get Alert |
ACRS | Aclaris Therapeutics | -$1.06 | -$0.57 | -$0.56 | 1.75% | $1.63M | $5.82M | $983.00K | -83.11% | 11/07/2019 | Get Alert |
ACRS | Aclaris Therapeutics | -$1.01 | -$0.76 | -$0.76 | 0.00% | $3.68M | $5.55M | $5.87M | 5.68% | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $-0.24 | $-0.29 | 17.2 % |
Dec 2023 | 2024-02-27 | $-0.30 | $-0.34 | 11.8 % |
Sep 2023 | 2023-11-06 | $-0.41 | $-0.48 | 14.6 % |
Jun 2023 | 2023-08-07 | $-0.42 | $-0.45 | 6.67 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $2.40M | $1.37M | 75.0 % |
Dec 2023 | 2024-02-27 | $17.57M | $3.36M | 422.9 % |
Sep 2023 | 2023-11-06 | $9.28M | $1.57M | 491.2 % |
Jun 2023 | 2023-08-07 | $1.87M | $1.90M | -1.63 % |
Aclaris Therapeutics (ACRS) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $-0.24, which beat the estimate of $-0.29.
The Actual Revenue was $2.4M, which beat the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.